Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-05-19

FDA Approved: EBANGA — Supplemental Application (Emergent Manufacturing Operations Baltimore, LLC)

View source ↗

Summary

The FDA approved a supplemental application for EBANGA (ansuvimab) from Emergent Manufacturing Operations Baltimore, LLC, authorizing changes to its manufacturi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ebanga (ansuvimab-zykl)

Snippet

SUPPL AP for EBANGA (ANSUVIMAB)